SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015574
Filing Date
2018-08-14
Accepted
2018-08-14 15:57:26
Documents
83
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20180630_10q.htm 10-Q 756537
2 EXHIBIT 31.1 ex_121615.htm EX-31.1 8723
3 EXHIBIT 31.2 ex_121616.htm EX-31.2 8649
4 EXHIBIT 32.1 ex_121617.htm EX-32.1 5792
5 EXHIBIT 32.2 ex_121618.htm EX-32.2 5801
  Complete submission text file 0001437749-18-015574.txt   4887096

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20180630.xml EX-101.INS 993110
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20180630.xsd EX-101.SCH 69865
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20180630_cal.xml EX-101.CAL 30168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20180630_def.xml EX-101.DEF 424647
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20180630_lab.xml EX-101.LAB 302169
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20180630_pre.xml EX-101.PRE 451649
Mailing Address 20 N REAR RD LAKESHORE A6 N0R 1A0
Business Address 20 N REAR RD LAKESHORE A6 N0R 1A0 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 181017133
SIC: 2834 Pharmaceutical Preparations